US Penny Stocks To Watch In November 2024

As of late November 2024, the U.S. stock market has been experiencing a robust rally, with major indices like the S&P 500 and Dow Jones Industrial Average reaching record highs. Amidst this bullish environment, investors are increasingly exploring diverse opportunities to capitalize on potential growth areas. Penny stocks, though often considered niche investments due to their lower price points and smaller company profiles, can still present compelling opportunities when backed by solid financial health. In this article, we'll explore several penny stocks that exhibit promising financial strength and potential for long-term success in the current market landscape.

Top 10 Penny Stocks In The United States

Name	Share Price	Market Cap	Financial Health Rating
BAB (OTCPK:BABB)	$0.7805	$5.74M	★★★★★★
QuantaSing Group (NasdaqGM:QSG)	$3.08	$142.61M	★★★★★★
Golden Growers Cooperative (OTCPK:GGRO.U)	$4.50	$69.71M	★★★★★★
ZTEST Electronics (OTCPK:ZTST.F)	$0.2255	$8.74M	★★★★★★
LexinFintech Holdings (NasdaqGS:LX)	$4.27	$559M	★★★★★★
Permianville Royalty Trust (NYSE:PVL)	$1.57	$51.15M	★★★★★★
Zynerba Pharmaceuticals (NasdaqCM:ZYNE)	$1.30	$65.6M	★★★★★☆
CBAK Energy Technology (NasdaqCM:CBAT)	$0.9511	$80.94M	★★★★★☆
Safe Bulkers (NYSE:SB)	$3.98	$435.65M	★★★★☆☆
VCI Global (NasdaqCM:VCIG)	$1.79	$5.64M	★★★★★☆

Click here to see the full list of 717 stocks from our US Penny Stocks screener.

Let's explore several standout options from the results in the screener.

QuantaSing Group (NasdaqGM:QSG)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: QuantaSing Group Limited offers online learning services in the People’s Republic of China and has a market cap of approximately $142.61 million.

Operations: The company's revenue primarily comes from Learning Service and Others, generating CN¥3.62 billion, with an additional CN¥173.96 million from its Consumer Business segment.

Market Cap: $142.61M

QuantaSing Group Limited, with a market cap of approximately US$142.61 million, has shown significant financial activity and growth. The company recently became profitable, reporting net income of CN¥196.61 million for the fourth quarter ended June 30, 2024. It has no debt and boasts an outstanding return on equity of 74.6%. Despite its profitability and high-quality earnings, QuantaSing's earnings are forecasted to decline by an average of 21.4% annually over the next three years. Its share price remains highly volatile but trades at a substantial discount to its estimated fair value, suggesting potential investment appeal amidst risks associated with penny stocks.

• Unlock comprehensive insights into our analysis of QuantaSing Group stock in this financial health report.
• Gain insights into QuantaSing Group's outlook and expected performance with our report on the company's earnings estimates.

Mammoth Energy Services (NasdaqGS:TUSK)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Mammoth Energy Services, Inc. is an energy services company operating in the United States, Canada, and internationally with a market cap of $164.60 million.

Operations: The company's revenue is primarily derived from its Infrastructure segment at $109.74 million, followed by Well Completion at $36.63 million, Sand at $18.40 million, and Drilling at $3.43 million.

Market Cap: $164.6M

Mammoth Energy Services, Inc., with a market cap of US$164.60 million, faces challenges as it navigates financial difficulties. The company reported a significant net loss of US$24.04 million for Q3 2024, compared to a smaller loss in the previous year, indicating ongoing profitability issues. Despite having sufficient short-term assets (US$255.2 million) to cover liabilities and an acceptable debt level with a net debt to equity ratio of 16.7%, the company's return on equity remains negative at -73.62%. Executive changes are underway as Phil Lancaster prepares to take over as CEO in January 2025 amidst these financial struggles.

• Dive into the specifics of Mammoth Energy Services here with our thorough balance sheet health report.
• Gain insights into Mammoth Energy Services' historical outcomes by reviewing our past performance report.

Milestone Scientific (NYSEAM:MLSS)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Milestone Scientific Inc. is a biomedical technology company that patents, designs, develops, and commercializes injection technologies and devices for medical, dental, and cosmetic use globally; it has a market cap of $61.61 million.

Operations: The company's revenue is primarily derived from its Dental segment, which accounts for $8.75 million, with an additional contribution of $0.13 million from the Medical segment.

Market Cap: $61.61M

Milestone Scientific Inc., with a market cap of US$61.61 million, is navigating the penny stock landscape with its innovative CompuFlo Epidural System, now approved for the Federal Supply Schedule (FSS). This positions the company to access federal healthcare markets, potentially expanding its revenue streams beyond its primary Dental segment. Despite being unprofitable and experiencing shareholder dilution, Milestone has reduced losses over five years and maintains a sufficient cash runway. Recent executive changes see Neal Goldman as Interim CEO following Arjan Haverhals' retirement, aiming to drive commercialization efforts further in this volatile market segment.

• Navigate through the intricacies of Milestone Scientific with our comprehensive balance sheet health report here.
• Learn about Milestone Scientific's future growth trajectory here.

Taking Advantage

• Reveal the 717 hidden gems among our US Penny Stocks screener with a single click here.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com